Original Assignee Sirna Therapeutics Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Abandoned Application number US10/831,620 Inventor James McSwiggen Leonid Beigelman Pamela Pavco Current Assignee (The listed assignees may be inaccurate. Google Patents RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)Äownload PDF Info Publication number US20050148530A1 US20050148530A1 US10/831,620 US83162004A US2005148530A1 US 20050148530 A1 US20050148530 A1 US 20050148530A1 US 83162004 A US83162004 A US 83162004A US 2005148530 A1 US2005148530 A1 US 2005148530A1 Authority US United States Prior art keywords sina nucleotides sina molecule molecule sequence Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US20050148530A1 - RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) US20050148530A1 - RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |